Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6680852 | 7365231 | I | 6680852-5 | 20100324 | 20100325 | 20100412 | EXP | TCI2010A01123 | TAKEDA PHARMACEUTICALS NORTH AMERICA | YR | F | N | 20100408 | OT | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6680852 | 1013499523 | PS | ACTOS | 1 | ORAL | (1 IN 1 D) | D | 21073 | |||
| 6680852 | 1013562516 | SS | MP-513 (CODE NOT BROKEN) (ORAL ANTIDIABETICS) | 2 | ORAL | MP-513 OR PLACEBO |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6680852 | 1013499523 | TYPE 2 DIABETES MELLITUS |
| 6680852 | 1013562516 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6680852 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6680852 | HAEMORRHOIDS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6680852 | FGN |
| 6680852 | HP |
| 6680852 | OTH |
| 6680852 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6680852 | 1013562516 | 20100213 |